Skip to content

4/AAccepted May 8, 5:35 PM ET

Hale David Robert 4/A

VRXValeant Pharmaceuticals International, Inc.

sec.gov(opens the filing on sec.gov)

Accepted (ET)

5:35 PM

May 8, 2018

Filed

May 8, 2018

Documents

1

Size

23.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.